Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating on Mounjaro is one of the most commonly reported side effects, and it has a straightforward biological cause: tirzepatide slows the rate at which your stomach empties, which means food and gas sit in your digestive system longer than usual. For most people the bloating is at its worst in the first few weeks or after a dose increase, then gradually settles. It is a prescription-only medicine, so any decision about managing symptoms or changing your dose belongs with your prescriber — not a forum thread. That said, there is a lot you can do day-to-day to make things more comfortable while your body adjusts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both the GIP and GLP-1 hormone receptors, slowing gastric emptying as part of how it reduces appetite. That slower transit is useful (it keeps you full longer) but it also means that swallowed air and fermented gas from food have more time to build up before they move on. The result is the distended, uncomfortable feeling that many people notice in their abdomen, particularly in the hours after eating.
You can read more about how tirzepatide works in the body on the tirzepatide overview page. The NHS medicines page for tirzepatide also lists bloating and related gastrointestinal effects among the known side effects of the medicine, so you are not imagining it and you are far from alone in experiencing it. The effect tends to be dose-dependent: if you want to understand what stepping up to a higher strength involves, the 100mg tirzepatide page explains what to expect at that level, including a fresh wave of GI symptoms for a week or two before things settle again.
One misconception worth letting go gently: many people assume the bloating means the treatment is not working or that something has gone wrong. It almost always means the opposite. The same mechanism causing the discomfort is the one reducing your appetite. The two come as a package, at least initially.
Once you understand that slower gastric emptying is the underlying cause, the things that help start to make sense. Eating more slowly gives your stomach time to process what is already there before more arrives. Large meals are harder to tolerate than smaller, more frequent ones, your stomach has less room to manoeuvre when emptying is already delayed. Fizzy drinks and sparkling water add gas directly to a system that is already struggling to clear it, so plain still water is a better choice during the adjustment period.
Certain foods are more likely to ferment and produce gas: cruciferous vegetables like broccoli and cabbage, beans, lentils, onions, and high-fat foods all tend to worsen symptoms. That is not a reason to cut them permanently (fibre and plant diversity matter for long-term health) but easing back while you settle on a new dose can make a real difference. The Mounjaro information page covers practical aspects of treatment in more detail.
Keeping moving after meals, even a short walk, can help gas shift. Lying down immediately after eating tends to make bloating worse. These adjustments are not dramatic, but patients consistently report that eating habits account for a large part of how uncomfortable the bloating actually feels.
If you are finding the discomfort hard to manage day to day, it is worth reading about what being bloated on Mounjaro involves, including how to tell whether what you are experiencing is within the typical range or something that warrants a closer look. There is a different category of abdominal symptom that matters more: severe, persistent stomach pain that does not settle, especially if it spreads toward your back or is accompanied by vomiting that will not stop. The MHRA issued a Drug Safety Update in January 2026 specifically flagging acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and severe, radiating abdominal pain is the key warning sign. It is uncommon, but it is the reason the distinction between ordinary bloating and something more serious matters.
If your bloating is genuinely severe, is getting worse over weeks rather than better, or is accompanied by signs of dehydration from persistent nausea and vomiting, contact your prescriber or GP. Do not wait for your next scheduled check-in. You can also report any suspected side effects through the MHRA's Yellow Card scheme, which helps build the national safety picture for newer medicines.
For a fuller discussion of what the bloating can feel like at different doses, the page on feeling bloated on Mounjaro goes into more practical detail from a patient perspective.
If bloating has been persistent for more than three or four weeks at the same dose, it is worth bringing up at your next clinical review. A prescriber can consider whether your titration pace is right for you, whether any other medicines or health conditions might be contributing, or whether a temporary pause before the next dose increase makes sense. These are not decisions to make unilaterally, stopping or adjusting your dose without clinical input can affect both safety and results.
For context on what treatment costs and what is included in a private prescription, the Mounjaro price comparison page explains what to look for when assessing different providers. If you are weighing up whether to continue or have questions about your current experience, our prescribers are available for support. You can also explore the broader weight-loss treatment options if you are at an earlier stage of deciding which route suits you.
The right question to ask yourself is not simply "how do I stop the bloating" but "is the bloating settling, and am I managing it well enough to stay the course?" For most people, with a few eating adjustments, the answer after a few weeks becomes yes. If it is not, that is a clinical conversation worth having, and you can speak to our prescribers to get a proper review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.